1,871 results on '"Novara, Giacomo"'
Search Results
202. IMPACT OF CLINICAL AND HISTOPATHOLOGICAL PARAMETERS ON DISEASE-SPECIFIC SURVIVAL IN PATIENTS WITH COLLECTING DUCT RENAL CELL CARCINOMA: 1074
203. INDEPENDENT VALIDATION OF THE 2010 TNM STAGING SYSTEM FOR RENAL CELL CARCINOMA: DOES IT IMPROVES PREDICTIVE ACCURACY IN CANCER-SPECIFIC MORTALITY COMPARED TO 2002 TNM?: 1076
204. PREDICTION OF INTRAVESICAL RECURRENCE AFTER RADICAL NEPHROURETERECTOMY: DEVELOPMENT OF A CLINICAL DECISION-MAKING TOOL: 896
205. The European Association of Urology Robotic Urology Section (ERUS) survey of robot-assisted radical prostatectomy (RARP)
206. Predictors of cancer-specific mortality after disease recurrence following radical cystectomy
207. Prediction of True Nodal Status in Patients with Pathological Lymph Node Negative Upper Tract Urothelial Carcinoma at Radical Nephroureterectomy
208. Obesity is associated with worse oncological outcomes in patients treated with radical cystectomy
209. Outcomes and prognostic factors in patients with a single lymph node metastasis at time of radical cystectomy
210. Psycho-social well-being and general health status after surgical treatment for localized renal cell carcinoma
211. Predictive pathological factors of lymph nodes involvement in the squamous cell carcinoma of the penis
212. Surgical Mesh Reconstruction for Post-hysterectomy Vaginal Vault Prolapse
213. Prognostic Indicators in Penile Cancer
214. Painless Scrotal Lumps: Classification and Clinics
215. Prognostic Role of the Histologic Subtypes of Renal Cell Carcinoma after Slide Revision
216. Anticholinergic Drugs in Patients with Bladder Outlet Obstruction and Lower Urinary Tract Symptoms: A Systematic Review
217. Needle Core Length is a Quality Indicator of Systematic Transperineal Prostate Biopsy
218. Prognostic role of tumour multifocality in renal cell carcinoma
219. PROSTATE CANCER: Epidemiologic studies and changing clinical practice
220. Critical Review of Guidelines for BPH Diagnosis and Treatment Strategy
221. Inflammation, Apoptosis, and BPH: What is the Evidence?
222. External Validation of the Mayo Clinic Stage, Size, Grade and Necrosis (SSIGN) Score to Predict Cancer Specific Survival Using a European Series of Conventional Renal Cell Carcinoma
223. International validation of the prognostic value of subclassification for AJCC stage pT3 upper tract urothelial carcinoma of the renal pelvis
224. Impact of tumour location versus multifocality in patients with upper tract urothelial carcinoma treated with nephroureterectomy and bladder cuff excision: a homogeneous series without perioperative chemotherapy
225. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series
226. DISEASE-FREE SURVIVAL AS A SURROGATE FOR 5-YEAR OVERALL SURVIVAL IN UPPER TRACT UROTHELIAL CARCINOMA: 392
227. Elective partial nephrectomy is equivalent to radical nephrectomy in patients with clinical T1 renal cell carcinoma: results of a retrospective, comparative, multi-institutional study
228. Prognostic role of ECOG performance status in patients with urothelial carcinoma of the upper urinary tract: an international study
229. Prognostic factors in a large multi-institutional series of papillary renal cell carcinoma
230. Editorial Comment
231. Zero-ischemia partial nephrectomy —further evaluations are needed
232. Racial differences in the outcome of patients with urothelial carcinoma of the upper urinary tract: an international study
233. Population-based analyses of radical cystectomy and urinary diversion for bladder cancer in northern Italy
234. Balancing continence function and oncological outcomes during robot-assisted radical prostatectomy (RARP)
235. Oncological outcomes after laparoscopic and open radical nephroureterectomy: results from an international cohort
236. Prognostic factors for upper urinary tract urothelial carcinoma
237. Discrepancy between clinical and pathological stage: external validation of the impact on prognosis in an international radical cystectomy cohort
238. Accuracy of on-bench biopsies in the evaluation of the histological subtype, grade, and necrosis of renal tumours
239. Disease-Free Survival at 2 or 3 Years Correlates With 5-Year Overall Survival of Patients Undergoing Radical Cystectomy for Muscle Invasive Bladder Cancer
240. Trifecta outcomes after robot-assisted laparoscopic radical prostatectomy
241. Obesity and Prostate Cancer: The Tip of a High Mountain Still to Be Conquered
242. Risk of SARS-CoV-2 Diffusion when Performing Minimally Invasive Surgery During the COVID-19 Pandemic
243. Risks from Deferring Treatment for Genitourinary Cancers: A Collaborative Review to Aid Triage and Management During the COVID-19 Pandemic
244. New Antiandrogen Compounds Compared to Docetaxel for Metastatic Hormone Sensitive Prostate Cancer: Results from a Network Meta-Analysis
245. Perioperative Mortality and Long-Term Survival after Radical Cystectomy: A Population-Based Study in a Southern European Country on 4,389 Patients
246. Surgical treatment for female stress urinary incontinence: what is the gold-standard procedure?
247. Association of Tumor Necrosis With Pathological Features and Clinical Outcome in 754 Patients Undergoing Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: An International Validation Study
248. Stage pT0 at Radical Cystectomy Confers Improved Survival: An International Study of 4,430 Patients
249. pT3 Substaging is a Prognostic Indicator for Lymph Node Negative Urothelial Carcinoma of the Bladder
250. Author reply: Neoadjuvant targeted therapy in renal cell carcinoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.